Table 1. Demographic and baseline characteristics by study group.
| Parameter | NGT N = 20 (100%) |
T2DM N = 20 (100%) |
|---|---|---|
| Gender (n (%)) | ||
| Male | 10 (50%) | 10 (50%) |
| Female | 10 (50%) | 10 (50%) |
| Age (years) | ||
| Mean / SD | 66.1 / 6.21 | 68.0 / 4.70 |
| 95% CI | 63.2–69.0 | 65.8–70.2 |
| BMI (kg/m2) | ||
| Mean / SD | 26.3 / 3.35 | 29.1 / 3.71 |
| 95% CI | 24.8–27.3 | 27.3–30.8 |
| HbA1c (%) | ||
| Mean / SD | 5.58 / 0.29 | 7.07 / 0.49 |
| 95% CI | 5.44–5.71 | 6.84–7.29 |
| Triglycerides (mmol/L) | ||
| Mean / SD | 1.11 / 0.5 | 2.0 / 1.49 |
| 95% CI | 0.88–1.35 | 1.30–2.70 |
| Waist circumference (cm) | ||
| Mean / SD | 93.9 / 12.9a | 102.0 / 10.0a |
| Mean systolic blood pressureb (mmHg) | ||
| Mean / SD | 140 / 16.1 | 139 / 17.8 |
| 95% CI | 133–148 | 131–148 |
| Mean diastolic blood pressureb (mmHg) | ||
| Mean / SD | 77.2 / 8.47 | 79.3 / 13.0 |
| 95% CI | 73.2–81.1 | 73.2–85.4 |
| Statins (n (%)) | 5 (25%) | 10 (50%) |
| Simvastatin | 3 (15%) | 8 (40%) |
| Atorvastatin | 2 (10%) | 1 (5%) |
| Fluvastatin | 0 | 1 (5%) |
NGT: subjects with normal glucose tolerance, T2DM: patients with type 2 diabetes, SD: standard deviation, CI: confidence interval
a n = 16
b mean value according to measurement of blood pressure at left and right arm